Meridian Bioscience, Inc. (VIVO): Are Hedge Funds Right About This Stock?

Page 2 of 2

Using the returns explained by our studies, regular investors should always track hedge fund and insider trading sentiment, and Meridian Bioscience, Inc. (NASDAQ:VIVO) shareholders fit into this picture quite nicely.

Discover how hedge fund piggybacking can benefit you

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) 11 0 0
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) 10 0 0
Neogen Corporation (NASDAQ:NEOG) 6 0 0
Quidel Corporation (NASDAQ:QDEL) 12 0 0
Abaxis Inc (NASDAQ:ABAX) 7 0 0
Page 2 of 2